I’d squirt the spray into my nose, where it’d drip to the back of my throat. The taste was potent: The office kept a dish of ...

While its effectiveness is still being researched, clinical therapists across the country and here at Bryan Medical say it’s mostly beneficial for treatment-resistant depression patients.

Spravato is the first ketamine-based medicine approved to treat depression, and also the first of a new class of glutamate NMDA receptor-targeting drugs that have ended a decades-long drought at ...

In the ESCAPE-TRD study, Spravato outperformed quetiapine on the main endpoint of achieving remission at eight weeks, measured by the Montgomery-Åsberg Depression Rating Scale (MADRS), with rates ...

The FDA granted approval to Spravato (esketamine) as the first monotherapy for adults with treatment-resistant depression, J&J said in a news release on Tuesday, Jan. 21.

Jen and Zac Affleck from "The Secret Lives of Mormon Wives" credit ketamine therapy for saving their marriage. A doctor discusses its use in depression treatment and potential risks.

Almost all the patients with depression who received Gilgamesh Pharmaceuticals ... framework that J&J established for its ketamine drug Spravato. Half the patients received 10 mg of GM-2505 ...

Jason Farrell, who retired from the RCMP after 10 years of service due to severe PTSD, says ketamine therapy has been the ...

Although Musk had previously mentioned using a "small amount once every other week," the billionaire X owner may have been using ketamine frequently enough on President Donald Trump 's campaign trail ...